R Thomas Marketing recalling supplements for erectile dysfunction

R Thomas Marketing LLC is voluntarily recalling all lots of the following products to the consumer level:

• Black Ant: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules total)
• Herb Viagra: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules)
• Real Skill: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules)
• Stree Overlord: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules)
• Weekend Prince: BIG BOX (24 individual cards / 2 capsules per card / 48 capsules)
• African Black Ant: BIG BOX (8 small boxes / 6 capsules per box / 48 capsules)

These products were tested by the FDA and found to contain Sildenafil, a PDE-5 Inhibitor which is the active ingredient in an FDA-approved drug for erectile dysfunction (ED) making this tainted dietary supplement and unapproved drug. recalling supplements for erectile dysfunction is not listed on the product labels.

Risk Statement: This undeclared active ingredient poses a threat to consumers because Sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Additionally, the product may cause side effects, such as headaches and flushing.

Out of an abundance of caution, R. Thomas Marketing is also recalling all lots of the following products previously sold at the consumer level because these products were sourced from the same vendors as the above-mentioned products and may have resulted in similar misbranding or the likelihood for misbranding to occur in the future:

• Bull: CASE (10 packs / 3 capsules per can / 30 capsules)
• Bulls Genital: CASE (10 Cans / 10 capsules per can / 100 capsules)
• Zhonghua Niu Bian: BIG BOX (6 small boxes / 6 capsules per box / 36 capsules)
• African Superman: BIG BOX (6 small boxes / 8 capsules per box / 48 capsules)
• Bigger Longer More Time More Sperms: BIG BOX (6 small boxes / 6 capsules per small box / 36 capsules)
• Black Ant King: BIG BOX (10 capsules / can / 12 cans per box / 120 capsules)
• Black Storm: SMALL BOX (6 capsules)
• Germany Niubian: BIG BOX (10 small boxes / 24 capsules per box / 240 capsules)
• Happy Passengers: BIG BOX (30 small boxes / 1 capsule per box / 30 capsules)
• Plant Vigra: BIG BOX / (18 cans / 6 capsules per can / 108 capsules)
• Hard Ten Days: BIG BOX (6 small boxes / 6 capsules per box / 36 capsules)
• Man King: BIG BOX (8 small boxes / 5 capsules per box / 40 capsules)
• Mojo Risen: BIG BOX (24 individual cards / 2 capsules per card/ 48 capsules)
• Night Man: SMALL BOX (6 capsules)
• Tiger King: BIG BOX (10 small bottles / 10 capsules per bottle / 100 capsules)
• Samurai-X: BIG BOX (24 individually wrapped capsules)
• Super Hard: BIG BOX (20 small boxes / 6 capsules per box / 120 capsules)
• Zhen Gong: BIG BOX (16 small boxes / 2 capsules per box / 32 capsules)

These products were marketed as dietary supplements for male sexual enhancement. The products are packaged in accordance with the respective identifiers listed above. All lots of the specified products sold by R Thomas Marketing via internet sales from September 2013 to present are included in this recall. The products were mainly sold through the following websites:

http://streeoverlord.us/
http://herbsviagra.com/
http://realskill.org/
http://www.blackantpills.us/
http://africanblackantpills.org/
http://africanblackantpills.com/
http://buddypills.com/
http://hobuck.com/
http://maleenhancers.net/
http://www.raffu.com/
http://africablackantking.net/

The products were sold through numerous websites (approximately 80), but these were the most commonly used. R Thomas Marketing is notifying its customers by issuing a press release and by direct notification via email.

Consumers and retailers that have any of these above mentioned products should stop using and/or distributing this product immediately and arrange return of the products to:

Attn: RECALL NOTICE
R Thomas Marketing LLC
20 Passaic St.
Trenton, NJ 08618

Consumers with questions regarding this voluntary recall can contact R Thomas Marketing LLC by email at rthomasmarketingbiz@gmail.com and/or calling at 914-278-0212. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report online: www.fda.gov/medwatch/report.htm
• Regular Mail or FAX: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request reporting form, then complete and return to the address on the pre-addresses form, or submit by fax to 1-800-FDA-0178.

This recall and market action are being conducted with the knowledge of the U.S. Food and Drug Administration.

Fuel Up Plus and Fuel Up High Octane recalled

Reesna Inc., Canoga Park, CA, is voluntarily recalling all lots of Fuel Up Plus and Fuel Up High Octane particularly distributed in August 2015 due to containing undeclared hydroxythiohomosildenafil, an analogue of sildenafil. Sildenafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Fuel Up an unapproved drug. The problem was found after FDA sampled the product and the results were positive for undeclared hydroxythiohomosildenafil.

Hydroxythiohomosildenafil is close in structure to sildenafil and is expected to possess a similar pharmacological and adverse event profile. This poses a threat to consumers because sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. No illnesses or injuries have been reported to the company to date in connection with this product.

Fuel Up is marketed as a dietary supplement sexual enhancer for men. The product was sold to distributors and retail stores nationwide and via internet sales.

Reesna Inc. is notifying its customers by email and telephone. Consumers should not consume Fuel Up and should return it immediately to the place of purchase for a full refund. Reesna is taking this voluntary action because of the concern for the health and safety of consumers. The company has discontinued distribution of these affected products. It sincerely regrets any inconvenience to our customers.

Consumers should contact their physician if they have experienced any problems that may be related to taking this product. Consumers with questions should contact Romy Navarro at 818-576-0576, Monday through Friday, 9:00 am to 5:00 pm, PST.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

• 
• 
• 
• 
• 

Health News: E. COLI can transfer antibiotic resistance to other bacteria ♦ An easy pill to swallow ♦ Erectile dysfunction drug may benefit patients at risk for diabetes

E. COLI can transfer antibiotic resistance to other bacteria Scientists have discovered a gene in E. coli that makes it resistant to a class of “last-resort” antibiotics known as polymyxins. The gene can also transfer resistance to other epidemic pathogens such as K. pneumoniae and Pseudomonas aeruginosa. According to research published in The Lancet Infectious Diseases, the mcr-1 gene is widespread in Enterobacteriaceae samples from pigs

New study on patterns of electronic cigarette use among adults in the US Adding to a growing body of research on patterns of e-cigarette use, researchers have found evidence that among US adults, some recent cigarette quitters may have done so with the assistance of electronic cigarettes

Erectile dysfunction drug may benefit patients at risk for diabetes The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers report.

An easy pill to swallow An insulin pill being developed by researchers may in the near future give another blood sugar management option to those who suffer from diabetes. The novel drug delivery technology may also apply to a wide spectrum of other therapies.

Health News: Peanuts ward off some foodborne illnesses ♦ MDR for vitamin D was miscalculated ♦ Detecting adverse reactions to medications using social media + more

Peanuts may help to ward off some foodborne illnesses  Eating the skinless inner kernels of peanuts may improve a person’s gut flora and its ability to ward off E. coli and Salmonella, according to a new study by researchers at the University of Maryland published in the Journal of Food Science. The findings suggest that skinless peanuts could be a beneficial promoter of gut bacteria that will Continue Reading

Groundbreaking approach to evaluate sleep disorders developed  "We've developed a non-contact 'breathing sound analysis' algorithm that provides a reliable estimation of whole-night sleep evaluation for detection of sleep quality, snoring severity and Obstructive Sleep Apnea," researchers explain of their newly developed diagnostic approach.  Continue Reading

Recommendation for vitamin D intake was miscalculated, is far too low  Researchers are challenging the intake of vitamin D recommended by the National Academy of Sciences Institute of Medicine saying their Recommended Dietary Allowance for vitamin D underestimates the need by a factor of ten. Continue Reading

Erectile dysfunction drug relieves nerve damage in diabetic mice   New animal studies found that sildenafil, a drug used to treat erectile dysfunction, may be effective in relieving painful and potentially life-threatening nerve damage in men Continue Reading

New system for detecting adverse effects of medications using social media A new system for detecting adverse effects of pharmaceutical drugs tracks information generated by patients on specialized blogs or social networks such as Twitter in real time. The researchers explain that online health information searches are the third most popular activity in Google, with 170,000 searches performed every 5 seconds. "There is a lot of user-generated information these days, so social networks can be a valuable source of information on adverse effects of pharmaceutical drugs Continue Reading

2/7/15 Health News: Gold in food not worth its weight in health ♦ Compound switches off epilepsy development ♦ Healthy' fat tissue could reverse diabetes ♦ Erectile dysfunction drugs could protect liver from damage

Gold in food not worth its weight in health

Is it necessary to add powdered gold to liquors? Should powdered gold at all be used as a food additive? Will consumption of gold harm human health? Such questions are still haunting the public despite an official agency issuing a statement to clarify a National Health and Family Planning Commission's draft seeking people's feedback by  Continue Reading

Novel compound switches off epilepsy development

A novel compound helps curtail the onset and progression of temporal lobe epilepsy, researchers have discovered. The finding may contribute to the development of antiepileptic therapies, they say. Continue Reading

Healthy' fat tissue could be key to reversing type 2 diabetes

Preventing inflammation in obese fat tissue may hold the key to preventing or even reversing type 2 diabetes. The scientists found they could 'reverse' type 2 diabetes in laboratory models by dampening the inflammation in fat tissue. Continue Reading

Erectile dysfunction drugs could protect liver from sepsis-induced damage

Drugs that are on the market to treat erectile dysfunction could have another use: they might be able to protect the liver from damage caused by sepsis, a systemic inflammatory response to infection, Continue Reading

New minimally invasive test identifies patients for Barrett's esophagus screening

A new minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression can be used to identify patients with reflux symptoms who warrant endoscopy to diagnose Barrett's esophagus, according to a new study Continue Reading